Andreas Wicki - Net Worth and Insider Trading
Andreas Wicki Net Worth
The estimated net worth of Andreas Wicki is at least $173 Million dollars as of 2024-05-09. Andreas Wicki is the Director of Viela Bio Inc and owns about 1,750,000 shares of Viela Bio Inc (VIE) stock worth over $93 Million. Andreas Wicki is the Director of Harmony Biosciences Holdings Inc and owns about 2,147,943 shares of Harmony Biosciences Holdings Inc (HRMY) stock worth over $67 Million. Andreas Wicki is also the Director of Pacira BioSciences Inc and owns about 451,324 shares of Pacira BioSciences Inc (PCRX) stock worth over $13 Million. Details can be seen in Andreas Wicki's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Andreas Wicki has not made any transactions after 2022-12-14 and currently still holds the listed stock(s).
Transaction Summary of Andreas Wicki
Andreas Wicki Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Andreas Wicki owns 3 companies in total, including Pacira BioSciences Inc (PCRX) , Harmony Biosciences Holdings Inc (HRMY) , and Viela Bio Inc (VIE) .
Click here to see the complete history of Andreas Wicki’s form 4 insider trades.
Insider Ownership Summary of Andreas Wicki
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PCRX | Pacira BioSciences Inc | 2021-03-15 | director |
| HRMY | Harmony Biosciences Holdings Inc | 2022-12-14 | director |
| VIE | Viela Bio Inc | 2019-10-07 | director |
Andreas Wicki Latest Holdings Summary
Andreas Wicki currently owns a total of 3 stocks. Among these stocks, Andreas Wicki owns 1,750,000 shares of Viela Bio Inc (VIE) as of October 7, 2019, with a value of $93 Million and a weighting of 53.49%. Andreas Wicki owns 2,147,943 shares of Harmony Biosciences Holdings Inc (HRMY) as of December 14, 2022, with a value of $67 Million and a weighting of 38.74%. Andreas Wicki also owns 451,324 shares of Pacira BioSciences Inc (PCRX) as of March 15, 2021, with a value of $13 Million and a weighting of 7.77%.
Latest Holdings of Andreas Wicki
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VIE | Viela Bio Inc | 2019-10-07 | 1,750,000 | 53.01 | 92,767,500 |
| HRMY | Harmony Biosciences Holdings Inc | 2022-12-14 | 2,147,943 | 31.28 | 67,187,657 |
| PCRX | Pacira BioSciences Inc | 2021-03-15 | 451,324 | 29.86 | 13,476,535 |
Holding Weightings of Andreas Wicki
Andreas Wicki Form 4 Trading Tracker
According to the SEC Form 4 filings, Andreas Wicki has made a total of 1 transactions in Viela Bio Inc (VIE) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Viela Bio Inc is the acquisition of 500,000 shares on October 7, 2019, which cost Andreas Wicki around $10 Million.
According to the SEC Form 4 filings, Andreas Wicki has made a total of 11 transactions in Harmony Biosciences Holdings Inc (HRMY) over the past 5 years, including 0 buys and 11 sells. The most-recent trade in Harmony Biosciences Holdings Inc is the sale of 28,841 shares on December 14, 2022, which brought Andreas Wicki around $2 Million.
According to the SEC Form 4 filings, Andreas Wicki has made a total of 4 transactions in Pacira BioSciences Inc (PCRX) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Pacira BioSciences Inc is the sale of 69,355 shares on March 15, 2021, which brought Andreas Wicki around $5 Million.
Insider Trading History of Andreas Wicki
- 1
Andreas Wicki Trading Performance
GuruFocus tracks the stock performance after each of Andreas Wicki's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Andreas Wicki is 42.55%. GuruFocus also compares Andreas Wicki's trading performance to market benchmark return within the same time period. The performance of stocks bought by Andreas Wicki within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Andreas Wicki's insider trading performs compared to the benchmark.
Performance of Andreas Wicki
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 13.72 | | | | | |
| Relative Return to S&P 500(%) | 10.71 | | | | | |
Andreas Wicki Ownership Network
Andreas Wicki Owned Company Details
What does Pacira BioSciences Inc do?
Who are the key executives at Pacira BioSciences Inc?
Andreas Wicki is the director of Pacira BioSciences Inc. Other key executives at Pacira BioSciences Inc include Chief Clinical Officer Roy Winston , Executive Director & Accounting Lauren Bullaro Riker , and CAO and General Counsel Kristen Marie Williams .
Pacira BioSciences Inc (PCRX) Insider Trades Summary
Over the past 18 months, Andreas Wicki made no insider transaction in Pacira BioSciences Inc (PCRX). Other recent insider transactions involving Pacira BioSciences Inc (PCRX) include a net sale of 8,216 shares made by Lauren Bullaro Riker , a net sale of 124,338 shares made by Gary W Pace , and a net sale of 9,125 shares made by Kristen Marie Williams .
In summary, during the past 3 months, insiders sold 119,323 shares of Pacira BioSciences Inc (PCRX) in total and bought 0 shares, with a net sale of 119,323 shares. During the past 18 months, 209,500 shares of Pacira BioSciences Inc (PCRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 209,500 shares.
Pacira BioSciences Inc (PCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Pacira BioSciences Inc Insider Transactions
Andreas Wicki Mailing Address
Above is the net worth, insider trading, and ownership report for Andreas Wicki. You might contact Andreas Wicki via mailing address: C/o Hbm Bioventures (cayman) Ltd., Centennial Towers,ste.305,2454 W.bay Rd., Grand Cayman E9 E9.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
